In addition, novel and most interesting data, together with our previous reports, indicate the potential involvement of MAP-Tau abnormalities in the molecular mechanisms underlying the pathogenesis of several neurodevelopmental disorders, in particular, those featuring hyperactivation of the mTOR pathway, including ASD [37,67,68,69,70]. The gene discussed is MTOR; the disease is neurodevelopmental disorder.